Menopause can accelerate age-related weight gain, increasing a woman’s odds of becoming overweight or obese, researchers said ...

Tirzepatide users on hormone therapy had added improvements in weight, cardiometabolic mar ...

A new study led by Mayo Clinic found that postmenopausal women receiving menopausal hormone therapy lost 35% more weight ...

ORLANDO -- Postmenopausal women using hormone therapy (HT) saw significantly greater weight loss while taking the dual GIP/GLP-1 receptor agonist tirzepatide than their counterparts not using HT, ...

NEW ORLEANS — Many of us who have tried to lose weight have been told we're just not trying hard enough. And for women after menopause, the newest study suggests it may be something completely out of ...

Using tirzepatide and menopause hormone therapy at the same time leads to increased weight loss in postmenopausal women with overweight or obesity compared to use of tirzepatide treatment alone, ...

Significantly greater total body weight loss was achieved by the menopausal hormone therapy vs the non-menopausal hormone therapy group (17 vs 14%). HealthDay News — In postmenopausal women with ...

The GLP-1 tirzepatide is only one half of the puzzle.

Fractyl Health is developing a shot that would program the body to make more of the GLP-1 hormone naturally, a risky bet that it can provide a longer-lasting benefit than blockbuster weight-loss drugs ...

The advertiser paid a fee to promote this sponsored article and may have influenced or authored the content. The views expressed in this article are those of the advertiser and do not necessarily ...

Genetic weight loss is reframing obesity medicine by explaining why diets and drugs fail—and how personalized treatment ...